BIO-TECHNE Corp — Director's Dealing 2016

Nov 18, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2016-11-16

Reporting Person: LUCAS ROGER C (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-11-16	Common Stock	S	100	$105.75	Disposed	4029	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$101.19	2026-10-26	Common Stock (3985)	3985	Direct
Stock Optoin (right to buy)	$91.78	2024-10-30	Common Stock (4000)	4000	Direct
Stock Option (right to buy)	$87.39	2023-10-30	Common Stock (4000)	4000	Direct
Stock Option (right to buy)	$87.34	2025-10-28	Common Stock (4260)	4260	Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2016.

F2: The option vests on the earlier of the one year anniversary of the grant date (10/27/17) or the date of Bio-Techne's 2017 annual meeting of shareholders.